| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.048 | 0.2 |